Part of UT Health San Antonio

Part of UT Health San Antonio

You are here

Basler

Contact

210-567-5643

basler@uthscsa.edu

For administrative calls, please contact:

Departments & Divisions

Clinical

Provider profile

Joseph W Basler, M.D.

Professor

Residency Program Director

Dr. Basler received his undergraduate and MD degrees from the University of Missouri. Between these, he completed his Ph.D. in Molecular Biology at the State University of New York in Buffalo, N.Y. After a Residency in Urology at Washington University in St. Louis, Missouri, he was the recipient of a 3-year American Cancer Society Career Development Award in Urologic Oncology and stayed on as faculty at Washington University from 1990 through 1998. In 1998 he joined the faculty of the UT Health San Antonio Division of Urologic Surgery as an Associate Professor. After the Division of Urology became the Department of Urology, Dr. Basler was promoted to Professor. Dr. Basler has published numerous scientific papers, book chapters, and has edited a textbook on Urologic Oncology in addition to serving as a scientific reviewer for several prominent urologic journals. In 2008, Dr. Basler served as the President of the Texas Urologic Society, representing over 400 member Urologists. He currently serves as Program Director for UT Health San Antonio Department of Urology.

 

  • Professional Background

    Education

    • 1990 - Residency - Urology - Washington University School of Medicine - Barnes Hospital
    • 1986 - Residency - Surgery - University of Missouri
    • 1984 - MD - Medicine - University of Missouri
    • 1983 - PhD - Molecular Biology - State University of New York
    • 1979 - MA - Molecular Biology - State University of New York
    • 1976 - MA - Biology - University of Missouri
    • 1974 - BA - Biology - University of Missouri

    Appointments

    • 9/2006 - Thomas P. Ball Professor of Urology and Program Director in Urology - The University of Texas Health Science Center at San Antonio, Urology, San Antonio

  • Instruction & Training

    • 10/2009 - Present, AUA Ultrasound Certification Course
    • 1/2006 - Present, Post-Doctoral Student Supervision, UTHSCSA Department of Urology
    • 9/1998 - Present, Post-Doctoral Student Supervision, University Hospital, VA Hospital, SRNW, St. Luke's
    • 9/1998 - Present, Intro to Clinical Surgery, The University of Texas Health Science Center
    • 9/1998 - Present, Surgery Clerkship, The University of Texas Health Science Center
    • 9/1998 - Present, Urology Selective, The University of Texas Health Science Center

  • Research & Grants

    Grants

    Federal

    Funding Agency NIH/NCI/Southwest Oncology Group Title A Phase III Blinded Study Of Immediate Post-TURBT Instillation Of Gemcitabine Versus Saline In Patients With Newly Diagnosed Or Occasionally Recurring Grade I/II Superficial Bladder Cancer (OCR #07-09) (SWOG S0337) Status Active Period 12/2007 - Present Role Co-Investigator Grant Detail   Funding Agency Center for Disease Control Title A Prospective Study on the Effect of Treatment on Health-Related Quality of Life for Men with Localized Prostate Cancer Status Active Period 9/2005 - Present Role Co-Investigator Grant Detail   Funding Agency NIH/NCI/EDRN/Johns Hopkins Univ/Univ. of Michigan Title EDRN PCA3 Validation Trial and Urinary Reference Set (Co-PI with Dr. Thompson as PI) Status Active Period 7/2009 - Present Role Co-Investigator Grant Detail   Funding Agency Veterans Administration Co-Operative Study Title Prostate Cancer Intervention Versus Observation Trial (PIVOT): A Randomized Trial Comparing Radical Prostatectomy Versus Palliative Expectant Management for the Treatment of Clinically Localized Prostate Cancer Status Active Period 8/2003 - Present Role Principal Investigator Grant Detail (study visits) (following 2 patients originally enrolled at other centers) Funding Agency NCI/UT MDACC Title A Randomized Controlled Trial Evaluating the Tissue Effects of Preoperative Finasteride versus Placebo for Patients with Clinically Organ-Confined Prostate Cancer Status Active Period 1/2007 - Present Role Co-Investigator Grant Detail   Funding Agency Veteran's Health Administration Title Chemotherapy After Prostatectomy (CAP) for High Risk Prostate Carcinoma: A Phase III Randomized Study (CSP #553) Status Active Period 6/2008 - Present Role Co-Investigator Grant Detail  

     

    Funding Agency UTHSCSA - Urology Title Establishment of a Data Base of Bladder Cancer in South Texas Status Active Period 2/2005 - Present Role Co-Investigator Grant Detail   Funding Agency UTHSCSA - ERAHC Title Phase II Study to Assess the Activity of Nexrutine? in Prostate Cancer Patients Undergoing Surgery and Radiation Therapy Status Active Period 10/2010 - Present Role Co-Investigator Grant Detail Phase II Study to Assess the Activity of Nexrutine? in Prostate Cancer Patients Undergoing Surgery and Radiation Therapy Funding Agency UTHSCSA-Urology Title Establishment of a Data Base of Kidney Cancer in South Texas (Dr. Parekh?s study, you were Sub-I) Status Active Period 7/2007 - Present Role Co-Investigator Grant Detail   Funding Agency UTHSCSA - PREF - Urology Title Identification of Protein and Genetic Biomarkers of Prostate Cancer and Risk Factors for Progression of Disease. Status Active Period 3/2002 - Present Role Co-Investigator Grant Detail   Funding Agency UTHSCSA - Urology Title Biomarker Discovery for Renal Cell Carcinoma Through Serum, Urine and Tissue Protein Profiles Status Active Period 3/2004 - Present Role Co-Investigator Grant Detail   Funding Agency UTHSCSA - Urology Title Tissue Bank and Data Base for Urologic Diseases (Sub-I on GU TISSUE BANK protocol Dept of Pathology) Status Active Period 7/2000 - Present Role Co-Investigator Grant Detail  

  • Publications

      Abstract

      Basler JW, Swanson GP, Jones WE 3rd, Ha CS, Jenkins CA, Kumar AP. Tolerance of Phellodendron amurense bark extract (Nexrutine R) in patients with human prostate cancer; 2015 Jan. Basler JW, Hilton WM, Lotan Y, Parekh DJ, Svatek RS. Alvimopan for prevention of postoperative paralytic ileus in radical cyctectomy patients: a cost-effectiveness analyis; 2013 Jun.

      Journal Article

      Basler JW. A Randomized, Double-blind, Placebo-controlled Trial Evaluating Tissue Effects of Short-term Finasteride Exposure in Clinically Organ-confined Prostate Cancer Urology 2014 Jan;.

      Not Specified

      Basler JW, Stowers SH, Kraus SR. Preoperative Anesthetic Evaluation and Clinical Decision Making 2014 Jan;:443-454.

  • Clinical

    Provider profile

    Board Certifications

    • American Board of Urology